2118 related articles for article (PubMed ID: 11698225)
1. The biology of human natural killer-cell subsets.
Cooper MA; Fehniger TA; Caligiuri MA
Trends Immunol; 2001 Nov; 22(11):633-40. PubMed ID: 11698225
[TBL] [Abstract][Full Text] [Related]
2. CD62L expression identifies a unique subset of polyfunctional CD56dim NK cells.
Juelke K; Killig M; Luetke-Eversloh M; Parente E; Gruen J; Morandi B; Ferlazzo G; Thiel A; Schmitt-Knosalla I; Romagnani C
Blood; 2010 Aug; 116(8):1299-307. PubMed ID: 20505160
[TBL] [Abstract][Full Text] [Related]
3. New miRNA Signature Heralds Human NK Cell Subsets at Different Maturation Steps: Involvement of miR-146a-5p in the Regulation of KIR Expression.
Pesce S; Squillario M; Greppi M; Loiacono F; Moretta L; Moretta A; Sivori S; Castagnola P; Barla A; Candiani S; Marcenaro E
Front Immunol; 2018; 9():2360. PubMed ID: 30374356
[TBL] [Abstract][Full Text] [Related]
4. Role of chemokines in the biology of natural killer cells.
Maghazachi AA
Curr Top Microbiol Immunol; 2010; 341():37-58. PubMed ID: 20369317
[TBL] [Abstract][Full Text] [Related]
5. Natural Killer Cells Generated From Human Induced Pluripotent Stem Cells Mature to CD56
Euchner J; Sprissler J; Cathomen T; Fürst D; Schrezenmeier H; Debatin KM; Schwarz K; Felgentreff K
Front Immunol; 2021; 12():640672. PubMed ID: 34017328
[TBL] [Abstract][Full Text] [Related]
6. CD56
Vujanovic L; Chuckran C; Lin Y; Ding F; Sander CA; Santos PM; Lohr J; Mashadi-Hossein A; Warren S; White A; Huang A; Kirkwood JM; Butterfield LH
Front Immunol; 2019; 10():14. PubMed ID: 30761123
[TBL] [Abstract][Full Text] [Related]
7. CD56bright human NK cells differentiate into CD56dim cells: role of contact with peripheral fibroblasts.
Chan A; Hong DL; Atzberger A; Kollnberger S; Filer AD; Buckley CD; McMichael A; Enver T; Bowness P
J Immunol; 2007 Jul; 179(1):89-94. PubMed ID: 17579025
[TBL] [Abstract][Full Text] [Related]
8. Human CD56bright and CD56dim natural killer cell subsets respond differentially to direct stimulation with Mycobacterium bovis bacillus Calmette-Guérin.
Batoni G; Esin S; Favilli F; Pardini M; Bottai D; Maisetta G; Florio W; Campa M
Scand J Immunol; 2005 Dec; 62(6):498-506. PubMed ID: 16316416
[TBL] [Abstract][Full Text] [Related]
9. Novel insights on human NK cells' immunological modalities revealed by gene expression profiling.
Hanna J; Bechtel P; Zhai Y; Youssef F; McLachlan K; Mandelboim O
J Immunol; 2004 Dec; 173(11):6547-63. PubMed ID: 15557145
[TBL] [Abstract][Full Text] [Related]
10. Evidence for NK cell subsets based on chemokine receptor expression.
Berahovich RD; Lai NL; Wei Z; Lanier LL; Schall TJ
J Immunol; 2006 Dec; 177(11):7833-40. PubMed ID: 17114454
[TBL] [Abstract][Full Text] [Related]
11. Toll-like receptor 8 agonists improve NK-cell function primarily targeting CD56
Veneziani I; Alicata C; Pelosi A; Landolina N; Ricci B; D'Oria V; Fagotti A; Scambia G; Moretta L; Maggi E
J Immunother Cancer; 2022 Jan; 10(1):. PubMed ID: 35091452
[TBL] [Abstract][Full Text] [Related]
12. Killer Ig-like receptor (KIR) genotype predicts the capacity of human KIR-positive CD56dim NK cells to respond to pathogen-associated signals.
Korbel DS; Norman PJ; Newman KC; Horowitz A; Gendzekhadze K; Parham P; Riley EM
J Immunol; 2009 May; 182(10):6426-34. PubMed ID: 19414796
[TBL] [Abstract][Full Text] [Related]
13. CD16- CD56+ natural killer cells after bone marrow transplantation.
Jacobs R; Stoll M; Stratmann G; Leo R; Link H; Schmidt RE
Blood; 1992 Jun; 79(12):3239-44. PubMed ID: 1375847
[TBL] [Abstract][Full Text] [Related]
14. Differential alteration of CD56(bright) and CD56 (dim) natural killer cells in frequency, phenotype, and cytokine response in chronic hepatitis C virus infection.
Miyagi T; Shimizu S; Tatsumi T; Nishio K; Hiramatsu N; Kanto T; Hayashi N; Takehara T
J Gastroenterol; 2011 Aug; 46(8):1020-30. PubMed ID: 21559771
[TBL] [Abstract][Full Text] [Related]
15. CD94 surface density identifies a functional intermediary between the CD56bright and CD56dim human NK-cell subsets.
Yu J; Mao HC; Wei M; Hughes T; Zhang J; Park IK; Liu S; McClory S; Marcucci G; Trotta R; Caligiuri MA
Blood; 2010 Jan; 115(2):274-81. PubMed ID: 19897577
[TBL] [Abstract][Full Text] [Related]
16. IL15 Infusion of Cancer Patients Expands the Subpopulation of Cytotoxic CD56
Dubois S; Conlon KC; Müller JR; Hsu-Albert J; Beltran N; Bryant BR; Waldmann TA
Cancer Immunol Res; 2017 Oct; 5(10):929-938. PubMed ID: 28842470
[TBL] [Abstract][Full Text] [Related]
17. CD56bright natural killer (NK) cells: an important NK cell subset.
Poli A; Michel T; Thérésine M; Andrès E; Hentges F; Zimmer J
Immunology; 2009 Apr; 126(4):458-65. PubMed ID: 19278419
[TBL] [Abstract][Full Text] [Related]
18. Analyses of phenotypic and functional characteristics of CX3CR1-expressing natural killer cells.
Hamann I; Unterwalder N; Cardona AE; Meisel C; Zipp F; Ransohoff RM; Infante-Duarte C
Immunology; 2011 May; 133(1):62-73. PubMed ID: 21320123
[TBL] [Abstract][Full Text] [Related]
19. An unusual CD56(bright) CD16(low) NK cell subset dominates the early posttransplant period following HLA-matched hematopoietic stem cell transplantation.
Dulphy N; Haas P; Busson M; Belhadj S; Peffault de Latour R; Robin M; Carmagnat M; Loiseau P; Tamouza R; Scieux C; Rabian C; Di Santo JP; Charron D; Janin A; Socié G; Toubert A
J Immunol; 2008 Aug; 181(3):2227-37. PubMed ID: 18641363
[TBL] [Abstract][Full Text] [Related]
20. Specific phenotype and function of CD56-expressing innate immune cell subsets in human thymus.
Gerstner S; Köhler W; Heidkamp G; Purbojo A; Uchida S; Ekici AB; Heger L; Luetke-Eversloh M; Schubert R; Bader P; Klingebiel T; Koehl U; Mackensen A; Romagnani C; Cesnjevar R; Dudziak D; Ullrich E
J Leukoc Biol; 2016 Dec; 100(6):1297-1310. PubMed ID: 27354408
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]